Trine Folseraas

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Liver transplantation in primary sclerosing cholangitis with hepatobiliary neoplasia: survival outcomes and impact of diagnostic uncertainty.

Liver transplantation in primary sclerosing cholangitis with hepatobiliary neoplasia: survival outcomes and impact of diagnostic uncertainty.

Journal: Scandinavian journal of gastroenterology

Published: August 04, 2026

Differences in immunosuppressive strategies for primary sclerosing cholangitis after liver transplantation.

Differences in immunosuppressive strategies for primary sclerosing cholangitis after liver transplantation.

Journal: Journal of hepatology

Published: February 09, 2026

Chronic liver disease is associated with earlier-stage cholangiocarcinoma diagnosis and improved prognosis: Findings from the GLOBAL-BTC registry.

Chronic liver disease is associated with earlier-stage cholangiocarcinoma diagnosis and improved prognosis: Findings from the GLOBAL-BTC registry.

Journal: Journal of hepatology

Published: February 06, 2026

Accurate detection of cholangiocarcinoma in primary sclerosing cholangitis using DNA methylation biomarkers in bile and plasma.

Accurate detection of cholangiocarcinoma in primary sclerosing cholangitis using DNA methylation biomarkers in bile and plasma.

Journal: JHEP reports : innovation in hepatology

Published: December 15, 2025

Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitis.

Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitis.

Journal: JHEP reports : innovation in hepatology

Published: November 11, 2025

Reply: Competing risk and surveillance thresholds for HCC in patients with PSC.

Reply: Competing risk and surveillance thresholds for HCC in patients with PSC.

Journal: Hepatology (Baltimore, Md.)

Published: November 06, 2025

Cholangiocarcinoma 2026: status quo, unmet needs and priorities.

Cholangiocarcinoma 2026: status quo, unmet needs and priorities.

Journal: Nature reviews. Gastroenterology & hepatology

Published: October 31, 2025

Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling.

Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling.

Journal: Nature metabolism

Published: October 17, 2025

Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitis.

Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitis.

Journal: Journal of hepatology

Published: August 27, 2025

Intrahepatic T cell analysis reveals Th17 and MAIT17 enrichment in primary sclerosing cholangitis.

Intrahepatic T cell analysis reveals Th17 and MAIT17 enrichment in primary sclerosing cholangitis.

Journal: JHEP reports : innovation in hepatology

Published: August 21, 2025

Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses.

Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses.

Journal: Hepatology (Baltimore, Md.)

Published: July 25, 2025

A retrospective evaluation of preemptive liver transplantation for bile duct dysplasia in primary sclerosing cholangitis: Balancing risks and benefits.

A retrospective evaluation of preemptive liver transplantation for bile duct dysplasia in primary sclerosing cholangitis: Balancing risks and benefits.

Journal: JHEP reports : innovation in hepatology

Published: June 19, 2025

Showing 1-12 of 72

Last Updated: 09/26/2026